Augmenting Strategies in Clozapine-Resistant Schizophrenia

By Remington Gary   Saha Amitabha   Chong Siow-Ann   Shammi Chekkera  

CNS Drugs, Vol. 20, Iss. 2, 2006-01 ,pp. : 171-171

Adis International

Access to resources Recommend Favorite

Aripiprazole Augmentation of Clozapine in Treatment-Resistant Schizophrenia: A Clinical Observation

By Ziegenbein Marc  

Clinical Drug Investigation, Vol. 26, Iss. 3, 2006-01 ,pp. : 117-124

Adis International

Access to resources Recommend Favorite

Therapy-resistant schizophrenia: a psychopharmacotherapeutic approach with an atypical antipsychotic drug (clozapine)

By Giannelli A.   Volonteacute M.V.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 340-340

Elsevier

Access to resources Recommend Favorite

Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia

By Bitter I.   Dossenbach M.R.K.   Brook S.   Feldman P.D.   Metcalfe S.   Gagiano C.A.   Furedi J.   Bartko G.   Janka Z.   Banki C.M.   Kovacs G.   Breier A.   for the Olanzapine HGCK Study Group  

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 28, Iss. 1, 2004-01 ,pp. : 173-180

Elsevier

Access to resources Recommend Favorite

Despite safety concerns, clozapine has a unique profile of clinical benefits in patients with treatment-resistant schizophrenia or schizophrenia-associated suicidality

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 23, Iss. 10, 2007-10 ,pp. : 9-13

Adis International

Access to resources Recommend Favorite